© 2022 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
August 24, 2021
The US Preventive Services Task Force has issued a B-graded recommendation statement lowering their recommended age for screening for type 2 diabetes from 40 to 35 years.
August 10, 2021
The latest recommendation statement reaffirms the USPSTF's 2014 guidance, which included a B recommendation for screening for gestational diabetes at 24 weeks of gestation or after.
May 25, 2021
The USPSTF has issued the organization's first recommendation on interventions for promoting healthy weight gain during pregnancy and also provided an overview of the evidence base used for the recommendation statement.
December 20, 2020
Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.
September 05, 2020
An analysis from ESC Congress 2020 is shedding further light on the effects of dulaglutide in patients with and without background metformin use.
August 31, 2020
The MiniMed 770G becomes the first system to receive approval for children in this age group.
August 27, 2020
A randomized trial found use of a closed-loop insulin delivery system was safe and effective in type 1 diabetics as young as 6 years of age.
August 24, 2020
An endocrinologist from New Jersey discusses the importance of flu shots in high-risk diabetic patients.
July 30, 2020
New data suggests bone density measurement follow-ups within 3 years of baseline assessment are unnecessary and a potential misuse of resources.
July 21, 2020
New data disputes the findings of previous observational studies examining the effects of levothyroxine on cardiac function.